v3.26.1
Fair Value Measures and Disclosures
6 Months Ended
Mar. 31, 2026
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block] Fair Value Measurements
Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis
The Company's financial assets measured at fair value on a recurring basis at March 31, 2026 and September 30, 2025, were as follows (in thousands):
  Gross Unrealized Classification on Balance Sheet
March 31, 2026Fair Value Level Cost or Amortized Cost Gains Losses Aggregate
Fair Value
Cash and Cash Equivalents Short-Term Investments Long-Term Investments
Changes in fair value recorded in other comprehensive income (loss):
Money market fundsLevel 1$597,742 $— $— $597,742 $597,742 $— $— 
Total cash equivalents$597,742 $— $— $597,742 $597,742 $— $— 
Changes in fair value recorded in other net income (expense):
Equity investments*$20,814 $— $— $20,814 
Total equity investments20,814 — — 20,814 
Total$618,556 $597,742 $— $20,814 
* Equity investments presented in the table above include investments without readily determinable fair values that are measured at fair value using net asset value ("NAV") as a practical expedient, or are measured at cost with adjustments for observable changes in price or impairments. The equity investments are not classified within the fair value hierarchy.
  Gross Unrealized Classification on Balance Sheet
September 30, 2025Fair Value LevelCost or Amortized Cost Gains Losses Aggregate
Fair Value
Cash and Cash Equivalents Short-Term Investments Long-Term Investments
Changes in fair value recorded in other comprehensive income (loss):
Money market fundsLevel 1$642,997 $— $— $642,997 $642,997 $— $— 
Total cash equivalents$642,997 $— $— $642,997 $642,997 $— $— 
Changes in fair value recorded in other net income (expense):
Equity investments*$15,693 $— $— $15,693 
Total equity investments15,693 — — 15,693 
Total$658,690 $642,997 $— $15,693 
* Equity investments presented in the table above include investments without readily determinable fair values that are measured at fair value using NAV as a practical expedient, or are measured at cost with adjustments for observable changes in price or impairments. The equity investments are not classified within the fair value hierarchy.
The Company uses the fair value hierarchy for financial assets and liabilities. The carrying amounts of other current financial assets and other current financial liabilities approximate fair value due to their short-term nature.
Interest income from cash, cash equivalents, and investments was $8.2 million and $9.3 million for the three months ended March 31, 2026 and 2025, respectively, and $17.1 million and $19.6 million for the six months ended March 31, 2026 and 2025, respectively. Interest income is included in other income (expense), net in the Company's consolidated income statements. There were no unrealized losses on investments held for a period greater than 12 months at March 31, 2026 and September 30, 2025.
The Company determined that as of March 31, 2026, there were no credit losses on any investments within its portfolio.
Assets Measured and Recorded at Fair Value on a Non-Recurring Basis
The Company's non-financial long-lived assets, which include goodwill and other intangible assets, are not required to be carried at fair value on a recurring basis. These non-financial assets are measured at fair value on a non-recurring basis when there is an indicator of impairment, and they are recorded at fair value only when impairment is recognized. The Company reviews goodwill for impairment annually, during the second quarter of each fiscal year, or as circumstances indicate the possibility of impairment. The Company monitors the carrying value of tangible and intangible long-lived assets for impairment whenever events or changes in circumstances indicate its carrying amount may not be recoverable.
Impairment charges related to non-financial long-lived assets for the three and six months ended March 31, 2026 and 2025 were not material.